GUO: Perfect
[DOI] [PubMed] [Google Scholar] 169.Ren H, Orozco IJ, Su Y, Suyama S, Gutierrez-Juarez R, Horvath TL, et al
The most commercially significant event in the GLP-1 market in 2026 is the opening of the generic semaglutide window
With age, GSH levels decrease by up to 50% compared to young subjects, contributing to increased oxidative stress and chronic low-grade inflammation (inflammaging). In the anti-ageing field, GSH IV acts on three main levels: direct neutralisation of free radicals and protection of dermal collagen, modulation of inflammation through NF-B inhibition, and reduction of melanogenesis through tyrosinase inhibition with clinically observable effects on skin tone and luminosity. The most robust clinical evidence concerns neuroprotection (improvement of motor symptoms in Parkinson's disease) and protection from chemotherapy-induced neuropathy
Annals of Pharmacotherapy
Moreover, both peptides also show the potential to strengthen tissue, offering an advantage for athletes who push their physical limits
